James W. Green - Mar 5, 2024 Form 4 Insider Report for HARVARD BIOSCIENCE INC (HBIO)

Role
Chief Executive Officer, Director
Signature
/s/ David Sirois, by power of attorney
Stock symbol
HBIO
Transactions as of
Mar 5, 2024
Transactions value $
$0
Form type
4
Date filed
3/7/2024, 04:03 PM
Previous filing
Jan 3, 2024
Next filing
Jun 7, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HBIO Common Stock Award $0 +215K +8.1% $0.00 2.87M Mar 5, 2024 Direct F1
transaction HBIO Common Stock Award $0 +215K +7.49% $0.00 3.08M Mar 5, 2024 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents an award of restricted stock units ("RSUs") that will vest in three equal installments on March 19, 2025, 2026, and 2027.
F2 The number of RSUs represents the target number of RSUs that may be earned based on achievement by the Company of certain performance criteria. The actual number of RSUs awarded may vary between 0% and 150% of the target, depending on the Company's performance. The performance period will end on December 31, 2026.
F3 Includes (a) the awards described in footnotes (1) and (2) above, (b) 235,427 RSUs that will vest in two equal installments on December 29, 2024 and 2025, (c) 52,346 RSUs that will vest on December 29, 2024, (d) 484,975 RSUs with performance based vesting conditions tied to relative total shareholder return and (e) 1,878,749 shares of common stock beneficially owned by the Reporting Person.